Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Jun Kim

Showing results (141-150 of 425) with videos related to

Pageof 43
Sort By:
Gut and Liver|September 20, 2019
Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage BJeong-Ju Yoo, Su Jong Yu, Bora Lee, et al.
Journal of Hepatology|March 17, 2019
Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trialYoung-Suk Lim, Geum-Youn Gwak, Jonggi Choi, et al.
Clinical and Molecular Hepatology|July 6, 2016
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two casesHyeki Cho, Yuri Cho, Eun Ju Cho, et al.
BMC Medical Genetics|December 18, 2020
A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean populationJung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 2, 2013
Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic veinHyo-Cheol Kim, Jeong-Hoon Lee, Jin Wook Chung, et al.
Journal of Bioenergetics and Biomembranes|September 19, 2016
Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditionsJeong-Ju Yoo, Dong Hyeon Lee, Yuri Cho, et al.
Hepatology (Baltimore, Md.)|October 10, 2018
PI3Kδ Is a Therapeutic Target in Hepatocellular CarcinomaEunkyong Ko, Hyun-Wook Seo, Eun Sun Jung, et al.
Gut and Liver|November 28, 2023
Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular CarcinomaYoung Chang, Su Jong Yu, Hyo-Cheol Kim, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 30, 2023
Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcomeJae Hyun Kim, Jae Young Lee, Su Jong Yu, et al.
BMB Reports|January 5, 2010
Putative association of DNA methyltransferase 1 (DNMT1) polymorphisms with clearance of HBV infectionJi Yong Chun, Joon Seol Bae, Tae June Park, et al.
Pageof 43

Showing results (141-150 of 425) with videos related to

Sort By:
Pageof 43
Gut and Liver|September 20, 2019
Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage BJeong-Ju Yoo, Su Jong Yu, Bora Lee, et al.
Journal of Hepatology|March 17, 2019
Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trialYoung-Suk Lim, Geum-Youn Gwak, Jonggi Choi, et al.
Clinical and Molecular Hepatology|July 6, 2016
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two casesHyeki Cho, Yuri Cho, Eun Ju Cho, et al.
BMC Medical Genetics|December 18, 2020
A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean populationJung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 2, 2013
Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic veinHyo-Cheol Kim, Jeong-Hoon Lee, Jin Wook Chung, et al.
Journal of Bioenergetics and Biomembranes|September 19, 2016
Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditionsJeong-Ju Yoo, Dong Hyeon Lee, Yuri Cho, et al.
Hepatology (Baltimore, Md.)|October 10, 2018
PI3Kδ Is a Therapeutic Target in Hepatocellular CarcinomaEunkyong Ko, Hyun-Wook Seo, Eun Sun Jung, et al.
Gut and Liver|November 28, 2023
Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular CarcinomaYoung Chang, Su Jong Yu, Hyo-Cheol Kim, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 30, 2023
Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcomeJae Hyun Kim, Jae Young Lee, Su Jong Yu, et al.
BMB Reports|January 5, 2010
Putative association of DNA methyltransferase 1 (DNMT1) polymorphisms with clearance of HBV infectionJi Yong Chun, Joon Seol Bae, Tae June Park, et al.
Pageof 43